Lataa...
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
PURPOSE: The objective of this study was to characterize the demographic and clinical profile of RRMS patients receiving fingolimod in Spain, and to evaluate drug effectiveness and safety in clinical practice. METHODS: This observational, retrospective, multicentre, nationwide study was performed at...
Tallennettuna:
| Julkaisussa: | PLoS One |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7117743/ https://ncbi.nlm.nih.gov/pubmed/32240213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0230846 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|